+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds?



Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds?



Fetal Diagnosis and Therapy 37(3): 206-210



To evaluate whether maternal serum α-fetoprotein (MSAFP) improves the detection rate for open neural tube defects (ONTDs) and ventral wall defects (VWD) in patients undergoing first-trimester and early second-trimester fetal anatomical survey. A cohort of women undergoing screening between 2005 and 2012 was identified. All patients were offered an ultrasound at between 11 weeks and 13 weeks and 6 days of gestational age for nuchal translucency/fetal anatomy followed by an early second-trimester ultrasound at between 15 weeks and 17 weeks and 6 days of gestational age for fetal anatomy and MSAFP screening. All cases of ONTD and VWD were identified via query of billing and reporting software. Sensitivity and specificity for detection of ONTD/VWD were calculated, and groups were compared using the Fisher exact test, with p < 0.05 as significance. A total of 23,790 women met the criteria for inclusion. Overall, 15 cases of ONTD and 17 cases of VWD were identified; 100% of cases were diagnosed by ultrasound prior to 18 weeks' gestation; none were diagnosed via MSAFP screening (p < 0.001). First-trimester and early second-trimester ultrasound had 100% sensitivity and 100% specificity for diagnosing ONTD/VWD. Ultrasound for fetal anatomy during the first and early second trimester detected 100% of ONTD/VWD in our population. MSAFP is not useful as a screening tool for ONTD and VWD in the setting of this ultrasound screening protocol.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053987801

Download citation: RISBibTeXText

PMID: 25034077

DOI: 10.1159/000363654


Related references

Msafp does not improve detection rate for open neural tube defects in patients who receive first- and early second-trimester ultrasounds for fetal anatomical survey. American Journal of Obstetrics and Gynecology 208(1): S158-S159, 2013

Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis. Danish Medical Bulletin 48(3): 127-145, 2001

The second trimester screening for fetal chromosomal aneuploidy and open neural tube defects. 2007

Second trimester maternal serum screening for fetal open neural tube defects and aneuploidy. Genetics in Medicine 6(6): 540-541, 2004

Amniotic fluid gel cholinesterase density ratios in fetal open defects of the neural tube and ventral wall. British Journal of Obstetrics and Gynaecology 90(3): 238-240, 1983

Prenatal diagnosis of neural tube and abdominal wall defects in the 2d trimester. Geburtshilfe und Frauenheilkunde 45(2): 98-100, 1985

Mid-second trimester organic acids in severe open neural tube defects. Journal of Obstetrics and Gynaecology 21(5): 483-487, 1995

EP06.06: The assessment of diagnosis of fetal neural tube defects by ultrasound in the first trimester. Ultrasound in Obstetrics & Gynecology 50: 285-285, 2017

First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenatal Diagnosis 13(8): 681-689, 1993

Differentiation of early first-trimester cranial neural tube defects. Ultrasound in Obstetrics and Gynecology 43(6): 711-712, 2014

Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects. Prenatal Diagnosis 31(5): 466-472, 2011

Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects. Prenatal Diagnosis 20(8): 680-682, 2000

Efficacy of ultrasound for prenatal diagnosis of open neural tube and ventral wall defects. American Journal of Obstetrics & Gynecology 178(1 Part 2): S27, 1998

Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. British Journal of Obstetrics and Gynaecology 99(1): 23-25, 1992

Computerized methods in differentiating ventral wall defects from neural tube defects using TIFF files. American Journal of Human Genetics 57(4 Suppl. ): A291, 1995